Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma
- 1 September 2020
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (9) , 1717-1726
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary CarcinomaJAMA Surgery, 2019
- PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and ElaborationAnnals of Internal Medicine, 2019
- Long-term prognosis of surgical treatment for early ampullary cancers and implications for local ampullectomyBMC Surgery, 2015
- Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancerBritish Journal of Surgery, 2015
- Ampullary Cancer: An OverviewAmerican Society of Clinical Oncology Educational Book, 2014
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statementBMJ, 2014
- Pancreaticoduodenectomy Is Curative in the Majority of Patients With Node-Negative Ampullary CancerArchives of Surgery, 2005
- Improved Survival for Adenocarcinoma of the Ampulla of VaterArchives of Surgery, 2003
- Factors Predictive of Survival in Ampullary CarcinomaAnnals of Surgery, 1998
- THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODELStatistics in Medicine, 1997